Subsequently, MCP-1 mRNA expression was evaluated by real-time RT-PCR in AML-12 cells treated with rMIF (100 ng/mL), LPS (100 ng/mL), or CCl4 (0.5 mM) with or without CD74- or CD44-siRNA transfection. The gene discussed is CCL2; the disease is acute myeloid leukemia.